StreetInsider.com News Articles

H.C. Wainwright Reiterates Buy Rating on Microbot Medical (MBOT)

Wed, 19 Aug 2026 06:48:19 -0400

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $12.00 price target on Microbot Medical (NASDAQ: MBOT).

The analyst commented: "Microbot Medical recently reported its 2Q26 financial results. Revenue was $241K, representing over 100% QoQ growth and beating our projection of $220K. Net loss was $5.6M, or ($0.08) per share, more than our estimated loss of $4.0M. Of note, the company commenced the full market release of the LIBERTY System in April 2026. Following Georgia, Florida, and New York, new health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania have adopted the LIBERTY System, with an increasing number of hospital

Microbot Medical (MBOT) PT Lowered to $4 at B.Riley

Fri, 14 Aug 2026 08:29:34 -0400

B.Riley analyst Anderson Schock lowered the price target on Microbot Medical (NASDAQ: MBOT) to $4.00 (from $5.00) while maintaining a Buy rating.

Form 8-K Microbot Medical Inc. For: Aug 11

Tue, 11 Aug 2026 10:28:00 -0400

si-local-file:///var/storage/secattach/20260811/26903434.html

Form 8-K Microbot Medical Inc. For: Aug 11

Tue, 11 Aug 2026 10:28:00 -0400

si-local-file:///var/storage/secattach/20260811/26903434.html

Microbot Medical revenue more than doubles in Q2 2026

Tue, 11 Aug 2026 09:20:33 -0400

Microbot Medical Inc. (NASDAQ: MBOT) reported revenue growth of more than 100% in its fiscal second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026, according to a 10-Q filing with the Securities and Exchange Commission.

The company attributed the increase to repeat orders, expanded utilization among existing customers, and new customer additions following the Full Market Release of its LIBERTY Endovascular Robotic System in mid-April 2026. The Full Market Release was launched at the Society of Interventional Radiology Annual Scientific Meeting.

New health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania adopted the LIBERTY System during

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Tue, 11 Aug 2026 09:20:00 -0400

Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded utilization among existing customers, and the acquisition of new customers since the Full Market Release in mid-April

The Company added new customers in Q3 while expanding into new states and sites of service

HINGHAM, Mass., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Tue, 11 Aug 2026 09:20:00 -0400

The Company added new customers in Q3 while expanding into new states and sites of service

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Tue, 11 Aug 2026 09:20:00 -0400

The Company added new customers in Q3 while expanding into new states and sites of service

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

Tue, 11 Aug 2026 09:20:00 -0400

The Company added new customers in Q3 while expanding into new states and sites of service

Form 10-Q Microbot Medical Inc. For: Jun 30

Tue, 11 Aug 2026 09:15:00 -0400

si-local-file:///var/storage/secattach/20260811/26902788.html

Form 10-Q Microbot Medical Inc. For: Jun 30

Tue, 11 Aug 2026 09:15:00 -0400

si-local-file:///var/storage/secattach/20260811/26902788.html

Form 8-K Microbot Medical Inc. For: Aug 06

Fri, 07 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260807/26891566.html

Form 8-K Microbot Medical Inc. For: Aug 06

Fri, 07 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260807/26891566.html

Form 8-K Microbot Medical Inc. For: Jul 21